Superstar singer Michael Jackson co-patented a "Method and means for creating anti-gravity illusion" in 1993.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20110189125 | Modulators of HSP70/DnaK Function and Methods of Use Thereof Compositions and methods for modulating HSP70 function, particularly for the targeted killing of cancer cells, are disclosed.... | 08/04/2011 |
| 20110166342 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved: | 07/07/2011 |
| 20110105324 | Herbicidal Compounds Based on N-Azinyl-N-Phenylsulfonylureas What is described are compounds of the formula (I) in which the respective substituents have the meanings given in the description. The compounds of the formula (I) can be used as herbicides and plant growth ... | 05/05/2011 |
| 20100240708 | Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives Disclosed are compounds, pharmaceutical compositions containing the compounds, methods for using the compounds and processes for making the compounds. More specifically, the disclosure relates to alpha-(N-benzenesulfonamido)cycloalkyl compounds that may inhibit one or b... | 09/23/2010 |
| 20100184986 | SULFONAMIDE-BASED ORGANOCATALYSTS AND METHOD FOR THEIR USE Organocatalysts, particularly proline sulfonamide organocatalysts, having a first general formula as follows are disclosed. Embodiments of a method for using these organocatalysts also are disclosed. The meth... | 07/22/2010 |
| 20100120725 | Substituted Phenylsulfonamide Inhibitors of Beta Amyloid Production Compounds of Formula I, wherein R1-R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these comp... | 05/13/2010 |
| 20100063076 | Endothelin receptor antagonists This invention relates to novel endothelin receptor antagonists, derivatives, acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and co... | 03/11/2010 |
| 20090318511 | SELECTIVE HYDROXAMATE BASED MMP INHIBITORS The present invention provides a compound of formula (I): said compound is inhibitor of MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by... | 12/24/2009 |
| 20090042929 | 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors There is provided a compound having Formula (I) R1-Z-R2 wherein R1 is a group selected from optionally substituted fused polycyclic groups, substituted alkyl groups, branched alkyl groups, and optionally substituted cycloalkyl groups Z i... | 02/12/2009 |
| 20090005394 | Endothelin receptor antagonists This invention relates to novel endothelin receptor antagonists, derivatives, acceptable acid addition salts, solvates, hydrates and polymorphs thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in ... | 01/01/2009 |
| 20080188659 | Method for Preparing Halogenated Amines This invention relates to methods for preparing halogenated amines.... | 08/07/2008 |
| 20080085900 | SULFONYLGUANIDINE COMPOUNDS AND PHARMACEUTICAL USES THEREOF Sulfonylguanidine compounds corresponding to the tautomeric formulas I and Ia, a method for producing them, pharmaceutical compositions containing them, and methods of using them to prepare medicaments and for treating various medical conditions. The sulfonylguanidine c... | 04/10/2008 |
| 20080076667 | Substituted fluoroalkoxyphenylsulfonylureas The invention relates to substituted fluoroalkoxyphenylsulfonylureas of the general formula (I) in which n, A, R1, R2, R3 and R4 are as defined in the description, to their use as plant treatment agents, in particu... | 03/27/2008 |
| 20060177717 | Fluorinated sulfonamide compounds and polymer electrolyte membranes prepared therefrom for use in electrochemical cells A fluorinated sulfonamide small molecule having the general structure wherein m, n and p are 0 to 3, with the proviso that m+n+p is equal to 1 to 4; A1 is an aromatic heterocyclic group, with the proviso that carbon atoms of the heterocyclic ring a... | 08/10/2006 |